| http://www.w3.org/ns/prov#value | - The authors note, the two study sets differed in patient characteristics including age, ethnicity and treatment regimens, but had comparable molecular features in the two high-risk subtypes. ???Gleason score remains the best indicator of overall prostate cancer survival to date, but if we are able to identify patients with a low Gleason score who, nevertheless, exhibit characteristics for developi
|
